Saudi Arabia is an important beauty market for skincare, hair care, body care, fragrance and selected makeup brands. However, an OEM/ODM quotation or an approved product sample does not automatically mean that a product is ready for Saudi notification, import or sale.
Private label buyers should connect the product brief, formula version, ingredient information, packaging artwork, product images and local applicant responsibilities before bulk production. Preparing these inputs early reduces the risk of approving a formula or printed package that later needs to change.
BioCosmOrigin is a Guangzhou-based cosmetics OEM/ODM manufacturing partner. We support overseas B2B beauty brands through product brief clarification, formula and sample coordination, packaging communication, production planning and communication with cooperative manufacturing resources.
This checklist is a project-planning guide, not legal or regulatory advice. The Saudi importer, local applicant or qualified regulatory consultant should confirm the current filing route and final requirements with the Saudi Food and Drug Authority (SFDA).
Start with the current SFDA notification route
SFDA's current cosmetic product notification service directs applicants to the unified Ghad system. The service steps include creating a Ghad account, selecting or adding a product, selecting or adding a manufacturer and completing conditions for imported cosmetics.
Some older SFDA pages and buyer documents may still refer to eCosma. Buyers should not rely on an old portal name or an earlier checklist without confirming the current process. SFDA's updated notification guidance notes the transition from the previous electronic system to Ghad.
For an OEM/ODM project, the practical step is to identify the Saudi applicant or importer before finalizing the formula and artwork. That party can confirm the current portal, account, notification and clearance responsibilities.
Confirm that the product is treated as a cosmetic
The SFDA cosmetics overview describes cosmetics as products intended for external parts of the body, teeth or oral mucosa for purposes such as cleaning, perfuming, protection, maintaining good condition or changing appearance or body odor. It also states that a product can be classified as a drug when it contains or is marketed with a medical claim.
This distinction affects the product brief. A face serum positioned for hydration or appearance is not the same as a product presented as treating a disease. A fragrance marketed for scent is not the same as an aromatherapy product claiming to help sleep or stop smoking.
Before sampling, record:
- Product category and intended use
- Application area and directions for use
- Cosmetic benefit language
- Claims that should not appear
- Target customer and sales channel
- Saudi applicant or importer responsible for classification review
The buyer should freeze the intended use and claims before approving final artwork.
Assign responsibilities before requesting documents
A common source of delay is asking the supplier to "handle SFDA" without naming the local party that owns the notification. The brand, Saudi importer, regulatory consultant, manufacturing partner, packaging supplier and testing laboratory may each hold different information.
Use a responsibility table before the first commercial sample:
| Workstream | Information owner or reviewer |
|---|---|
| Saudi account and filing | Local applicant, importer or regulatory partner |
| Product classification and claims | Local regulatory reviewer with brand approval |
| Formula and ingredient data | Manufacturing-side technical team and formula owner |
| Artwork and label files | Brand and packaging team, reviewed for the Saudi market |
| Product and package images | Brand, packaging supplier or production team |
| Manufacturer information and authorization | Relevant manufacturer or authorized commercial party |
| Import and clearance documents | Saudi importer and logistics or customs partners |
Our responsible person and importer responsibilities guide explains why a manufacturing partner does not automatically replace the buyer's local compliance roles.
Build the notification data pack before bulk production
SFDA's current notification service lists several core conditions, including manufacturer or distributor authorization, a clear product image, artwork and label images, and an ingredient list with concentrations and functions.
For project planning, create one controlled data pack containing:
- Product and brand name
- Product category and intended use
- Formula code and version
- Complete ingredient list
- Ingredient concentrations and functions where required for filing
- Manufacturer and relevant commercial-party details
- Authorization document requested by the local applicant
- Inner and outer packaging artwork
- Clear product images from all required views
- Package size, directions, warnings and storage information
- Country-of-origin and batch-coding plan
- Supporting test, specification or safety information requested for the project
The exact submission set should be confirmed by the Saudi applicant. Do not assume that a general export document folder is the same as the notification file.
Control the ingredient file and formula version
The SFDA service page states that ingredients must be entered with their concentrations and functions. It also describes manual entry or use of a readable ingredient file based on the designated format.
This makes formula version control important. The ingredient file used for notification should correspond to the formula approved for production. A late change to a preservative, colorant, fragrance, active material or concentration can create differences between the sample, notification data and production specification.
Ask these questions before formula approval:
- Does the ingredient file match the current sample code?
- Are INCI names and ingredient functions reviewed?
- Are concentrations available to the authorized filing party under suitable confidentiality controls?
- Are restricted ingredients, colorants, preservatives and UV filters reviewed for the target product?
- Is there a process for notifying the buyer if the formula changes?
- Who confirms the final file before notification and bulk production?
The buyer should also agree how confidential formula information is shared and who is authorized to receive it.
Review artwork as notification data, not only design
Packaging artwork is often approved for appearance before regulatory information is complete. For a Saudi project, the artwork review should be connected to the product identity, claims, ingredient list, warnings, directions, size, country of origin, responsible commercial party and other target-market information.
Use the cosmetic label and artwork approval checklist to track version numbers and written approvals. The Saudi applicant should confirm language, placement and market-specific label requirements before printing.
Keep these files separate:
- Editable artwork source
- Print-ready artwork version
- Inner package label
- Outer carton label
- Leaflet, if used
- Product image for publication or portal display
- Photos showing the final product from the required views
The SFDA service distinguishes label artwork from the final product image. A flat design file should not automatically be treated as a substitute for a clear image of the finished package.
Plan change control after notification
The SFDA service explains that listed product information can be updated when a change does not alter the product identity or basic composition, while a change to product identity may require a new entry.
Before approving any post-notification change, ask the Saudi applicant whether it affects the existing record. Changes that deserve review include:
- Formula or ingredient changes
- Product name or intended-use changes
- Major claim changes
- Packaging format or size changes
- Manufacturer or commercial-party changes
- Artwork, warning or language changes
- Product image changes
Do not let a packaging reprint or formula adjustment move directly into production without checking notification impact.
One-page Saudi notification readiness checklist
Before confirming bulk production, the buyer should be able to answer:
- Who is the Saudi applicant or importer?
- Which current SFDA or Ghad route applies?
- Is the product classified and marketed as a cosmetic?
- Are intended use and claims frozen?
- Does the ingredient file match the approved formula version?
- Are ingredient concentrations and functions available to the authorized filing party?
- Are manufacturer and authorization details prepared?
- Are inner and outer artwork files approved for the target market?
- Are clear finished-product images available or scheduled?
- Are testing and supporting documents assigned to named parties?
- Is the notification timing connected to packaging and production timing?
- Is there a change-control process after notification?
Buyers should also align notification planning with the cosmetics export documentation checklist and the cosmetics OEM/ODM manufacturing process.
How BioCosmOrigin supports Saudi-market projects
BioCosmOrigin can help overseas brands organize manufacturer-side inputs for Saudi-oriented private label projects. Depending on the product and agreed scope, support may include product brief clarification, formula and ingredient-document communication, sample coordination, packaging artwork discussion, production planning and communication with cooperative manufacturing resources.
We do not replace the Saudi importer, applicant, SFDA account holder or qualified regulatory reviewer. The most efficient workflow is for the buyer's Saudi partner to provide a current requirement list while the product and manufacturing teams prepare the matching information.
To discuss a project, send your product brief with the product category, target market, formula direction, packaging format, expected quantity, launch timing and Saudi notification support questions.
Short Q&A for private label buyers
Can a China OEM/ODM partner complete the Saudi filing for every buyer?
Not automatically. The buyer should confirm the Saudi applicant, importer, account and regulatory responsibilities. The manufacturing side can prepare agreed product and manufacturer information but should not be assumed to own every local filing task.
Should SFDA planning start after bulk production?
No. Classification, claims, formula data, artwork and product-image requirements can affect sampling, printing and production timing. Discuss them before final approval.
Is a product image the same as packaging artwork?
No. SFDA's service page distinguishes artwork and label information from a clear image of the product. Confirm the required files and views with the local applicant.
Does notification guarantee that every claim is acceptable?
Buyers should not treat notification as a substitute for claim, label or market review. The intended use and claims still need to remain consistent with cosmetic classification and current requirements.
